Multiple-day dexamethasone for controlling delayed chemotherapy-induced nausea and vomiting with low-emetic-risk chemotherapy. [PDF]
Yamashita A +12 more
europepmc +1 more source
Effect of Music Relaxation Training Combined with Hierarchical Nursing Management on Vomiting Symptoms and Psychological Resilience in Patients with Chemotherapy-Induced Nausea and Vomiting. [PDF]
Zhou L, Zhang J, Yang L.
europepmc +1 more source
Zero Events, Limited Precision, and the Interpretation of Olanzapine Safety in Patients with Diabetes Receiving Cisplatin [Response to Letter]. [PDF]
Hayashi T +4 more
europepmc +1 more source
Comparative effectiveness and safety of ondansetron-based dual versus triple antiemetic regimens for chemotherapy-induced nausea and vomiting. [PDF]
Yu X +9 more
europepmc +1 more source
Efficacy and Safety of Oral NEPA Versus Fosaprepitant Plus Palonosetron for Preventing Chemotherapy-Induced Nausea and Vomiting in Patients with Nasopharyngeal Carcinoma: A Propensity-Score-Matched Retrospective Study. [PDF]
Cai Y +7 more
europepmc +1 more source
A randomized, double-blind, placebo-controlled trial of olanzapine versus placebo plus ondansetron and dexamethasone for antiemetic prophylaxis in patients receiving oxaliplatin-, irinotecan-, or carboplatin-based chemotherapy. [PDF]
Harikul W +6 more
europepmc +1 more source
Symptoms Experienced by Breast Cancer Patients Before, During and After Chemotherapy: A Systematic Review. [PDF]
Cao Y +6 more
europepmc +1 more source
Efficacy of steroid-omitting antiemetic therapy in patients with advanced pancreatic cancer receiving nano-liposomal irinotecan plus fluorouracil and leucovorin. [PDF]
Tokito Y +10 more
europepmc +1 more source
Neuropharmacology of Cannabinoids: A Comprehensive Review of Preclinical and Clinical Evidence for Hemp-Derived Extracts and Active Compounds. [PDF]
Odonkor CA +3 more
europepmc +1 more source

